Advanced search
Publication Cover
International Journal of General Medicine Volume 8, 2015 - Issue
Submit an article Journal homepage
151
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib-based chemotherapy

Junmei ZhaoHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of China
,
Chao WangHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of China
,
Yongping SongHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of China
,
Yuzhang LiuHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of China
&
Baijun FangHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 211-214 | Published online: 12 Jun 2015

References

  • AtraAGerrardMHobsonRImesonJDHannIMPinkertonCROutcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin’s lymphoma treated with the UKCCSG 9003/9002 protocolsBr J Haematol2001112496596811298592
  • MartinoRBellidoMBrunetSAllogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemiaBone Marrow Transplant19982110102310279632276
  • MartinoRBellidoMBrunetSIntensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trialHaematologica199984650551010366793
  • WeissMATreatment of adult patients with relapsed or refractory acute lymphoblastic leukemia (ALL)Leukemia199711Suppl 4S28S309179279
  • DewarRChenSTYeckes-RodinHMillerKKhosravi-FarRBortezomib treatment causes remission in a Ph+ ALL patient and reveals FoxO as a theranostic markerCancer Biol Ther201111655255821282974
  • HuXXuJSunAShenYHeGGuoFSuccessful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activityLeuk Lymphoma201152122393239521745166
  • SpecchiaGPastoreDCarluccioPFLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemiaAnn Hematol2005841279279516047203
  • CortesJThomasDKollerCPhase I study of bortezomib in refractory or relapsed acute leukemiasClin Cancer Res200410103371337615161691
  • AttarECDe AngeloDJSupkoJGPhase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemiaClin Cancer Res20081451446145418316568
  • FaderlSRaiKGribbenJPhase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemiaCancer2006107591692416832816
  • HuguetFLeguayTRaffouxEPediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 studyJ Clin Oncol200927691191819124805
  • ChalandonYThomasXHayetteSFirst Results of the GRAAPH-2005 Study in younger Adult Patients with De Novo Philadelphia Positive Acute Lymphoblastic Leukemia: 50th ASH Annual Meeting and Exposition, San Francisco, CA, USA, 6–9 December 2008Blood20081122
  • KantarjianHMO’BrienSSmithTLResults of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemiaJ Clin Oncol200018354756110653870

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.